XIENCE Sierra™ 1550400-33Recalls & reported problems
Abbott Vascular Inc. · XIENCE Sierra™ Everolimus Eluting Coronary Stent System 4.00 mm x 33 mm / Rapid-Exchange · Class 3 · Implant
All models of XIENCE Sierra (56)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08717648227530), received between May 26, 2020 and Apr 8, 2024 — classified as 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Device Dislodged or Dislocated1
- Difficult to Remove1
- Failure to Advance1
- Improper or Incorrect Procedure or Method1
- Off-Label Use1
- Patient-Device Incompatibility1
Patient problems
- No Consequences Or Impact To Patient2
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 8, 2024Improper or Incorrect Procedure or Method; Improper or Incorrect Procedure or Method
SUBSEQUENTLY, AFTER THE INITIAL WAS FILED IT WAS NOTED THAT THE STENT WAS IMPLANTED IN THE MID RIGHT CORONARY ARTERY. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19061029 ↗InjurySep 9, 2020Off-Label Use; Patient-Device Incompatibility; Off-Label Use; Patient-Device Incompatibility
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A LESION IN THE TIBIAL ARTERY BELOW THE KNEE. AN UNSPECIFIED GUIDE WIRE WAS ADVANCED AND ATHERECTOMY WAS PERFORMED. AN UNSPECIFIED BALLOON CATHETER WAS ADVANCED AND THE LESION WAS DILATED; HOWEVER, A PERFORATION WAS NOTED. FIVE NON-ABBOTT STENTS WERE DEPLOYED AND TREATED THE PERFORATION IN THE ANTERIOR TIBIAL ARTERY. IN THE POSTERIOR TIBIAL ARTERY (PTA) FIVE XIENCE SIERRA STENTS (3.5X28MM, 3.5X38MM, 4.0X33MM, 4.0X38MM, AND 4.0X38MM) WERE DEPLOYED OVERLAPPING EACH OTHER. THREE OF THE STENTS SEALED THE AREA OF THE PERFORATION SUCCESSFULLY; HOWEVER, TWO OF THE STENTS (4.0X33MM AND 4.0X38MM) DID NOT. PROLONGED BALLOON INFLATION WAS DONE FOR 10 MINUTES AND THE PERFORATION WAS NOT SEALED AND THE PATIENT CONTINUED BLEEDING. A 4.0X19MM GRAFTMASTER COVERED STENT AND A 3.5X19MM GRAFTMASTER COVERED STENT WERE DEPLOYED ON TOP OF THE DEPLOYED 4.0X33MM AND 4.0X38MM XIENCE SIERRA STENTS TO SUCCESSFULLY TREAT THE LONG PERFORATION IN THE PTA. DUE TO THE LONG PERFORATION AND EXCESSIVE BLEEDING DURING TREATMENT THE PATIENT SUFFERED FROM COMPARTMENT SYNDROME AND WAS SENT TO SURGERY FOR A FASCIOTOMY ON THE SAME DAY. NO ADDITIONAL INFORMATION WAS
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10512234 ↗MalfunctionMay 26, 2020Difficult to Remove; Failure to Advance; Device Dislodged or Dislocated; Difficult to Remove; Failure to Advance; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION LOCATED IN THE PROXIMAL LEFT ANTERIOR DESCENDING CORONARY ARTERY. AFTER A FAILED ATTEMPT TO CROSS WITH THE XIENCE STENT DELIVERY SYSTEM, THERE WAS RESISTANCE DURING REMOVAL AND THE STENT CAME OFF THE SHAFT. THE STENT WAS EASILY REMOVED WITH THE GUIDE WIRE WHEN THE GUIDE WIRE WAS REMOVED. THERE WAS NO REPORTED ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. A NON-ABBOTT STENT WAS USED TO COMPLETE THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10089799 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page